About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our Mission: To drive translational and clinical research in rehabilitation, from pathophysiology and cellular mechanisms to functional recovery. Our goal is to generate applicable knowledge to optimize clinical practice and health outcomes.
Our Vision: To be an international benchmark in Physical Medicine and Rehabilitation, leading innovative solutions to prevent and treat disability, while consistently promoting autonomy and quality of life.
Our Values: We are a multidisciplinary team (rehabilitation, neurophysiology, physiotherapy, occupational therapy, speech therapy, and biology) working alongside prestigious universities (UAB, URL, Andorra, and Deusto). We are defined by:
IP: Susana Rodriguez Gonzalez Collaborators: - Funding agency: AAL International Association Funding: 138162.64 Reference: AAL/2020/RODRIGUEZ_NEST Duration: 01/07/2021 - 31/01/2024
IP: - Collaborators: Laura Gutierrez García-Moreno, Jordi Lozano Torres, Alba Gómez Garrido, Lydia Dux-Santoy Hurtado, PATRICIA LAUNOIS OBREGÓN, Filipa Xavier De Carvalho Negrao Valente, Raul Aguilar Lopez Funding agency: Instituto de Salud Carlos III Funding: 45375 Reference: PI21/00448 Duration: 01/01/2022 - 30/06/2026
IP: Alberto Sandiumenge Camps Collaborators: María Deu Martín, Aroa Gomez Brey, Alba Gómez Garrido, Cristopher Alan Mazo Torre, Gonzalo Ballesteros Reviriego, Bernat Planas Pascual Funding agency: Fundación Invest. Médica Mutua Madrileña Funding: 40000 Reference: AP176932021 Duration: 01/09/2021 - 31/08/2024
IP: Susana Rodriguez Gonzalez Collaborators: Mª Engracia Perez Mesquida, Xavier Buxo Masip Funding agency: Instituto de Salud Carlos III Funding: 132112.64 Reference: AC21_1/00007 Duration: 01/01/2022 - 31/12/2024
MouthX, developed by the company Aurax, allows people with reduced mobility in the upper extremities to have access to essential digital tools for communication, work and leisure, with the aim of improving their independence and emotional well-being.
The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine
En la mateixa trobada la SEP va decidir atorgar per primera vegada una beca per fer formació a l'estranger de dos mesos. La beca es va atorgar a la Dra. Teresa Crespo, adjunta a la Unitat de Lesionats Medul·lars de Vall d’Hebron.
